Infectious Disease Diagnostics Market : Shares, Strategies and Forecasts, Analysis and Overview upto 2026
Infectious diseases are caused by microorganisms such as bacteria and viruses. These microorganisms are normally harmless; however, under specific conditions, they may cause a disease. Infectious diseases can be transmitted from one person to another or they can be transmitted through animal bites. Hence, infectious diseases are also known as transmissible diseases. Fever, diarrhea, fatigue, and coughing are some of the symptoms of infectious diseases. According to the Global Burden of Disease Study–2013, infectious diseases caused 9.2 million death across the globe in 2013.
View Report: https://www.transparencymarketresearch.com/infectious-disease-diagnostics-market.html
Based on product, the global infectious disease diagnostics market can be segmented into assays and kits & reagents. The kits & reagents segment is likely to expand at a significant pace during the forecast period, as kits and reagents are fast-moving consumable things that are used in the diagnostic procedure to conduct the diagnostic test. Based on disease type, the market can be segmented into hepatitis, HIV, TB, influenza, and others. The hepatitis segment is likely to expand at a significant pace during the forecast period, as the prevalence of hepatitis is increasing across the globe at a higher pace compared to other disease types. Based on technology, the infectious disease diagnostics market can be segmented into immunodiagnostics, PCR, NGS, and others.
The PRC (polymerase chain reaction) segment is likely to expand at a significant pace during the forecast period, as the polymerase chain reaction permits analysis of any short sequence of DNA even if the sample contains only minute quantities of nucleotides. In terms of end-user, the global infectious disease diagnostics market can be segmented into hospitals, diagnostic laboratories, and research institutes. The hospitals segment is likely to expand at a significant pace during the forecast period, as most patients prefer to visit hospitals so as to obtain the treatment and diagnosis at the same place. Moreover, compared to other end-users, a larger number of diagnostic tests are conducted in hospitals.
Increase in the prevalence of infectious diseases such as TB and influenza is one of the major factors fueling the global infectious disease diagnostics market. Moreover, rise in funding for research on the diagnosis of infectious diseases is projected to drive the market during the forecast period. However, undeveloped health care infrastructure in underdeveloped countries is likely to hamper the market in the next few years.
Request a Brochure of the Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=43667
In terms of region, the global infectious disease diagnostics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global market. The region is projected to account for a significant share of the global market during the forecast period, due to rise in the prevalence of infectious diseases and presence of a highly developed health care system in the region.
Presence of leading national clinical laboratories such as Eurofins Scientific and easy accessibility of advanced instruments that can be used in diagnostic procedures are a few factors that are likely to drive the Europe market from 2018 to 2026. Increase in the prevalence of infectious diseases and rise in the adoption of advanced diagnostic tools in the health care system in the region are likely to fuel the market in Asia Pacific during the forecast period. Rise in the prevalence of diseases such as malaria, meningitis, and rubella in central Africa is likely to augment the infectious disease diagnostics market in Middle East & Africa during the forecast period.
Request TOC @https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=43667
Key players operating in the global infectious disease diagnostics market are Abbott, Becton, Dickinson and Company (BD), bioMérieux SA, Bio-Rad Laboratories, Inc., Alere, Inc., Ortho-Clinical Diagnostics, and F. Hoffmann-La Roche Ltd.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Contact Us
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453